BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 20170)

  • 1. Dissociation of growth hormone and prolactin response to levodopa during pyridoxine administration.
    Delitala G; Masala A
    Biomedicine; 1977 Jul; 27(6):219-22. PubMed ID: 20170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB; Scott CL; Modebe O; Bethune JE
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of somatostatin, levodopa and pyridoxine on growth hormone (GH) secretion in newborn infants.
    Delitala G; Meloni T; Masala A; Alagna S; Devilla L; Costa R
    Biomedicine; 1978 Feb; 29(1):13-5. PubMed ID: 667280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of pimozide-induced prolactin secretion by piridoxine (vitamin B6).
    Delitala G; Masala A; Alagna S
    Biomedicine; 1977 Jul; 27(5):191-2. PubMed ID: 562688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoxine and depression: neuroendocrine aspects.
    Casacchia M; Boni B; Meco G
    Acta Vitaminol Enzymol; 1982; 4(1-2):55-8. PubMed ID: 6812398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pyridoxine on pituitary release of growth hormone and prolactin in childhood and adolescence.
    Reiter EO; Root AW
    J Clin Endocrinol Metab; 1978 Sep; 47(3):689-90. PubMed ID: 263321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of experimentally induced hyperprolactinemia on growth hormone secretion.
    Esquifino AI; Fernández-Ruiz JJ; Cebeira M; Agrasal C; Tresguerres JA; Ramos JA
    Rev Esp Fisiol; 1987 Dec; 43(4):463-8. PubMed ID: 3448711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic modulation of growth hormone, prolactin and thyroid stimulating hormone responses to thyrotropin-releasing hormone in normal aging.
    Giusti M; Giovale M; Sessarego P; Carraro A; Pompei A; Giordano G
    Recenti Prog Med; 1995 Sep; 86(9):341-4. PubMed ID: 7569294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of acetylsalicylic acid and diclofenac on stimulated growth hormone and prolactin secretion in humans.
    Caviezel F; Cattaneo AG; Tell A; Corino T; Mascherpa M
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):502-4. PubMed ID: 6642786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.
    Lancranjan I; Wirz-Justice A; Pühringer W; Del Pozo E
    J Clin Endocrinol Metab; 1977 Sep; 45(3):588-93. PubMed ID: 302840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic evaluation of prolactin secretion during the early hours of life in human newborns.
    Delitala G; Meloni T; Masala A; Alagna S; Devilla L; Corti R
    J Clin Endocrinol Metab; 1978 Jun; 46(6):880-2. PubMed ID: 122439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of papaverine to alter L-dopa-influenced GH and PRL secretion.
    Cooper DS; Jacobs LS
    J Clin Endocrinol Metab; 1977 Mar; 44(3):585-7. PubMed ID: 838852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of l-DOPA and sulpiride on growth hormone secretion at different injection times in Holstein steers.
    Kasuya E; Sutoh M; Yayou KI
    Anim Sci J; 2017 Nov; 88(11):1842-1848. PubMed ID: 28585780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
    Woolf PD; Lantigua R; Lee LA
    J Clin Endocrinol Metab; 1979 Sep; 49(3):326-30. PubMed ID: 468965
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic regulation of growth hormone (GH) secretion in normal man: correlation of L-dopa and dopamine levels with the GH response.
    Bansal S; Lee LA; Woolf PD
    J Clin Endocrinol Metab; 1981 Aug; 53(2):301-6. PubMed ID: 7251816
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
    Delitala G; Maioli M; Pacifico A; Brianda S; Palermo M; Mannelli M
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1145-9. PubMed ID: 6688812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxine (B6) suppresses the rise in prolactin and increases the rise in growth hormone induced by exercise.
    Moretti C; Fabbri A; Gnessi L; Bonifacio V; Fraioli F; Isidori A
    N Engl J Med; 1982 Aug; 307(7):444-5. PubMed ID: 7088124
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
    Leblanc H; Yen SS
    Am J Obstet Gynecol; 1976 Sep; 126(2):162-4. PubMed ID: 961756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.